BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17892523)

  • 41. [Ineffective esophageal motility].
    Leandri C; Guillaumot MA; Dohan A; Leconte M; Coriat R; Chaussade S; Barret M
    Presse Med; 2019 Sep; 48(9):897-903. PubMed ID: 31471090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study.
    Grossi L; Spezzaferro M; Sacco LF; Marzio L
    Neurogastroenterol Motil; 2008 Jul; 20(7):760-6. PubMed ID: 18373654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts.
    De Jonge PJ; Siersema PD; Van Breda SG; Van Zoest KP; Bac DJ; Leeuwenburgh I; Ouwendijk RJ; Van Dekken H; Kusters JG; Kuipers EJ
    Aliment Pharmacol Ther; 2008 Jul; 28(1):127-36. PubMed ID: 18384663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population.
    Solhpour A; Pourhoseingholi MA; Soltani F; Zarghi A; Solhpour A; Habibi M; Zali MR
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):719-25. PubMed ID: 18617775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus.
    El-Serag HB; Wieman M; Richardson P
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1293-9. PubMed ID: 18363892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces.
    Farré R; van Malenstein H; De Vos R; Geboes K; Depoortere I; Vanden Berghe P; Fornari F; Blondeau K; Mertens V; Tack J; Sifrim D
    Gut; 2008 Oct; 57(10):1366-74. PubMed ID: 18593808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reflux Aspiration Associated with Oesophageal Dysmotility but Not Delayed Liquid Gastric Emptying.
    Khoma O; Mendu MJ; Sen AN; Van der Wall H; Falk GL
    Dig Dis; 2021; 39(5):429-434. PubMed ID: 33378754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The significance of histological evidence of bile reflux gastropathy in patients with gastro-esophageal reflux disease.
    Nakos A; Zezos P; Liratzopoulos N; Efraimidou E; Manolas K; Moschos J; Molivas E; Kouklakis G
    Med Sci Monit; 2009 Jun; 15(6):CR313-8. PubMed ID: 19478703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-achalasic motor disorders of the oesophagus.
    Sifrim D; Fornari F
    Best Pract Res Clin Gastroenterol; 2007; 21(4):575-93. PubMed ID: 17643902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Night-time and daytime atypical manifestations of gastro-oesophageal reflux disease: frequency, severity and impact on health-related quality of life.
    Dean BB; Aguilar D; Johnson LF; McGuigan JE; Orr WC; Fass R; Yan N; Morgenstern D; Dubois RW
    Aliment Pharmacol Ther; 2008 Feb; 27(4):327-37. PubMed ID: 18005248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastro-oesophageal acid-related disease, co-morbidity and medical care cost.
    Jayadevappa R; Chhatre S; Weiner M
    Chronic Illn; 2008 Sep; 4(3):209-18. PubMed ID: 18796510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of pathological duodenogastric reflux and the relationship between duodenogastric and duodenogastrooesophageal reflux in chronic gastrooesophageal reflux disease.
    Brillantino A; Monaco L; Schettino M; Torelli F; Izzo G; Cosenza A; Marano L; Di Martino N
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1136-43. PubMed ID: 18946360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized clinical trial of laparoscopic total (Nissen) versus posterior partial (Toupet) fundoplication for gastro-oesophageal reflux disease based on preoperative oesophageal manometry.
    Booth MI; Stratford J; Jones L; Dehn TC
    Br J Surg; 2008 Jan; 95(1):57-63. PubMed ID: 18076018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
    Malhotra A; Freston JW; Aziz K
    J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnosis of proximal gastro-oesophageal reflux in patients with rhonchopathy and sleep apnoea].
    Esteller More E; Huerta Zumel P; Modolell Aguilar I; Segarra Isern F; Matiñó Soler E; Enrique González A; Ademà Alcover JM
    Acta Otorrinolaringol Esp; 2007 Dec; 58(10):464-9. PubMed ID: 18082076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3).
    de Vries DR; ter Linde JJ; van Herwaarden MA; Smout AJ; Samsom M
    Am J Gastroenterol; 2009 Feb; 104(2):281-5. PubMed ID: 19174793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux.
    Crowell MD; Bradley A; Hansel S; Dionisio P; Kim HJ; Decker GA; DiBaise JK; Sharma VK
    Am J Gastroenterol; 2009 Mar; 104(3):553-9. PubMed ID: 19223881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.